SCHEMBL3787786

SCHEMBL3787786

CC(C)NC(=O)c1ccc2c(c1)CCCO2

nearest known ligand 0.61

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 3/20 0.61
TAS1R1 Q7RTX1 3/20 0.61
CTNNB1 P35222 7/20 0.54
WNT3A P56704 7/20 0.54
SMN1; SMN2 Q16637 1/20 0.50
PIR O00625 1/20 0.48
HSF1 Q00613 1/20 0.48
RAB9A P51151 2/20 0.48
NPC1 O15118 1/20 0.48
PRKCI P41743 1/20 0.48
CACNA1H O95180 1/20 0.46
ROCK2 O75116 1/20 0.45
ROCK1 Q13464 1/20 0.45
FOXO1 Q12778 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL671055 0.82 CTNNB1 (0.57) TAS1R3TAS1R1CTNNB1WNT3ASMN1; SMN2
SCHEMBL27312616 0.82 CTNNB1 (0.57) TAS1R3TAS1R1CTNNB1WNT3APIR
SCHEMBL28860886 0.82 CTNNB1 (0.60) TAS1R3TAS1R1CTNNB1WNT3APIR
SCHEMBL3788073 0.81 CTNNB1 (0.53) TAS1R3TAS1R1CTNNB1WNT3ASMN1; SMN2
SCHEMBL1726294 0.80 CTNNB1 (0.61) TAS1R3TAS1R1CTNNB1WNT3APIR
SCHEMBL3787714 0.80 HPGD (0.54) TAS1R3TAS1R1CTNNB1WNT3ASMN1; SMN2
SCHEMBL3807781 0.79 NPC1 (0.63) CTNNB1WNT3ASMN1; SMN2RAB9ANPC1
SCHEMBL24169997 0.79 ALDH1A1 (0.58) SMN1; SMN2RAB9ANPC1
SCHEMBL20932779 0.79 ALDH1A1 (0.59) SMN1; SMN2RAB9ANPC1
SCHEMBL31262479 0.79 CTNNB1 (0.67) TAS1R3TAS1R1CTNNB1WNT3ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2234486-A1 BENZIMIDAZOLES AND ANALOGS AS RHO KINASE INHIBITORS The Scripps Research Institute (US) 2010-10-06 EP disclosed
WO-2009079011-A1 BENZIMIDAZOLES AND ANALOGS AS RHO KINASE INHIBITORS THE SCRIPPS RESEARCH INSTITUTE (US) 2009-06-25 WO disclosed